Hallvard Haugen

1.4k total citations · 1 hit paper
10 papers, 1.1k citations indexed

About

Hallvard Haugen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Hallvard Haugen has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Hallvard Haugen's work include Phagocytosis and Immune Regulation (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Liver physiology and pathology (3 papers). Hallvard Haugen is often cited by papers focused on Phagocytosis and Immune Regulation (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Liver physiology and pathology (3 papers). Hallvard Haugen collaborates with scholars based in Norway, United States and Israel. Hallvard Haugen's co-authors include James B. Lorens, Crina Tiron, Christine Gjerdrum, Jonna Nevo, Santeri Kiviluoto, Karoliina Vuoriluoto, Johanna Ivaska, David Micklem, Tone Sandal and Shan Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Hallvard Haugen

10 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer

2010 510 citations Karoliina Vuoriluoto, Hallvard Haugen et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hallvard Haugen Norway	6	517	515	414	181	144	10	1.1k
Christine Gjerdrum Norway	3	488 0.9×	514 1.0×	385 0.9×	158 0.9×	148 1.0×	6	1.1k
Evangeline Mose United States	18	551 1.1×	563 1.1×	283 0.7×	239 1.3×	123 0.9×	25	1.2k
Yuexi Shi United States	14	563 1.1×	837 1.6×	226 0.5×	254 1.4×	91 0.6×	27	1.3k
Ruben Bill Switzerland	11	554 1.1×	557 1.1×	374 0.9×	333 1.8×	108 0.8×	20	1.2k
Michael K. Asiedu United States	13	726 1.4×	614 1.2×	261 0.6×	287 1.6×	152 1.1×	17	1.2k
Jingda Xu China	17	643 1.2×	771 1.5×	390 0.9×	242 1.3×	81 0.6×	24	1.4k
Ewa Zając United States	14	457 0.9×	528 1.0×	445 1.1×	309 1.7×	66 0.5×	20	1.2k
Christophe Schneider France	19	307 0.6×	617 1.2×	307 0.7×	242 1.3×	131 0.9×	41	1.1k
Ningfeng Fiona Li United Kingdom	11	505 1.0×	457 0.9×	587 1.4×	216 1.2×	50 0.3×	11	1.2k
Jason Hatakeyama United States	13	390 0.8×	678 1.3×	702 1.7×	176 1.0×	101 0.7×	17	1.3k

Countries citing papers authored by Hallvard Haugen

Since Specialization

Citations

This map shows the geographic impact of Hallvard Haugen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hallvard Haugen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hallvard Haugen more than expected).

Fields of papers citing papers by Hallvard Haugen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hallvard Haugen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hallvard Haugen. The network helps show where Hallvard Haugen may publish in the future.

Co-authorship network of co-authors of Hallvard Haugen

This figure shows the co-authorship network connecting the top 25 collaborators of Hallvard Haugen. A scholar is included among the top collaborators of Hallvard Haugen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hallvard Haugen. Hallvard Haugen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Nalwoga, Hawa, et al.. (2016). Novel anti-human Axl monoclonal antibodies for improved patient biomarker studies. Diagnostic Pathology. 2(1). 1 indexed citations

Tiron, Crina, Gro Gausdal, Tone Sandal, et al.. (2014). Abstract 1747: BGB324, a selective small molecule Axl kinase inhibitor to overcome EMT-associated drug resistance in carcinomas: Therapeutic rationale and early clinical studies. Cancer Research. 74(19_Supplement). 1747–1747. 12 indexed citations

Gausdal, Gro, Tone Sandal, Stefan Hinz, et al.. (2014). Abstract B30: Selective small molecule AXL inhibitor BGB324 overcomes acquired drug resistance in non-small cell lung carcinoma models.. Clinical Cancer Research. 20(2_Supplement). B30–B30. 1 indexed citations

Olsen, Jan Roger, Anne M. Øyan, Kari Rostad, et al.. (2013). p63 Attenuates Epithelial to Mesenchymal Potential in an Experimental Prostate Cell Model. PLoS ONE. 8(5). e62547–e62547. 29 indexed citations

Olsen, Jan Roger, Xisong Ke, Kari Rostad, et al.. (2012). Abstract 1290: The ability of the transcription factor p63 to induce selected gene expression modules associated with mesenchymal to epithelial transition of prostate cells. Cancer Research. 72(8_Supplement). 1290–1290. 1 indexed citations

Sapkota, Dipak, Ove Bruland, Daniela Elena Costea, et al.. (2010). S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9. European Journal of Cancer. 47(4). 600–610. 51 indexed citations

Vuoriluoto, Karoliina, Hallvard Haugen, Santeri Kiviluoto, et al.. (2010). Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene. 30(12). 1436–1448. 510 indexed citations breakdown →

Gjerdrum, Christine, Crina Tiron, Torill Høiby, et al.. (2009). Abstract B105: Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Molecular Cancer Therapeutics. 8(12_Supplement). B105–B105. 1 indexed citations

Gjerdrum, Christine, Crina Tiron, Torill Høiby, et al.. (2009). Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proceedings of the National Academy of Sciences. 107(3). 1124–1129. 458 indexed citations

10.

Stavem, P, et al.. (1976). Nonsecretory Myelomatosis without Intracellular Immunoglobulin. Scandinavian Journal of Haematology. 17(2). 89–95. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact